Samuel J. Christensen

Samuel Christensen practices at Family Healthcare in Saint George, Utah.

Samuel Christensen's NPI, 1780114934, was assigned on June 19, 2017. Samuel Christensen holds Utah license 11539237-1204.

Samuel Christensen's primary practice is Family Healthcare, at 2276 E Riverside Dr, Saint George, UT 84790 in Washington County. The practice phone is (435) 879-5101.

Samuel Christensen's primary practice is Family Healthcare in Saint George, Utah. Samuel Christensen is also affiliated with St. George Regional Hospital. The medical group on file is Family Healthcare. Dmand AI also links Samuel Christensen to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Samuel Christensen practices, 2 sites in all. Vendor and product names are available with a free account.

Family medicine is Samuel Christensen's primary specialty in the NPI Registry, under taxonomy code 207Q00000X. Samuel Christensen is licensed in Utah.

CMS data shows 149 Medicare services from Samuel Christensen across 4 procedure codes in 2024, for 45 Medicare patients. Medicare paid $7,155 for them. Every service was in an office.

CMS counts 45 Medicare patients who saw Samuel Christensen in 2024. The largest group is 65 to 74, with 22 patients. 67% of them have high blood pressure, and 56% have diabetes. 24% are also on Medicaid. Their average risk score is 0.98, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Samuel Christensen's median patient age at 55, with 48% women.

In 2024, Samuel Christensen wrote 2,003 Medicare Part D claims for 165 patients. 79% of them were for generic drugs. CMS names the drug for 1,488 of them, across 47 drugs with 11 or more claims each, at $282,339 in total drug cost. In 2023, CMS named 1,068 claims across 38 drugs.

Samuel Christensen accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 86 general payments to Samuel Christensen from 14 drug and device companies from 2020 to 2025. Food and beverage make up the largest share, 100% of the total. AstraZeneca Pharmaceuticals LP paid the most, $498.